Home › Genetic Technologies Regains Compliance With Nasdaq Listing Rules

Genetic Technologies Regains Compliance With Nasdaq Listing Rules

Jan 09, 2018

NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies announced today that it has regained compliance with the Nasdaq's $1 minimum bid price requirement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In Molecular Diagnostics

  1. Qiagen to Develop Companion Dx for Novartis Breast Cancer Drug

  2. Grail Launches New Early Cancer Detection Study, Refocuses Strategy to Multi-Cancer Test

    Premium

  3. Cancer Whole-Genome and Transcriptome Test Expands NYGC's Clinical Services

    Premium

  4. SpeeDx Gets CE-IVD Mark for Antibiotic-Resistant Gonorrhea MDx

  5. New York State Approves OneOme PGx Test

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.